Akebia Therapeutics Inc. buy Leerink Partnrs
Start price
30.04.25
/
50%
€2.11
Target price
30.04.26
-
Performance (%)
-44.00%
End price
01.05.26
€1.18
Summary
This prediction ended on 01.05.26 with a price of €1.18. Massive losses of -44.00% were the result for the BUY prediction by Leerink_Partnrs. Leerink_Partnrs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | -3.386% | -3.386% | -63.889% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Leerink_Partnrs for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Leerink_Partnrs gewählte maximale Laufzeit wurde überschritten